The Latest Breaking News from GSK

Panadol and Chapstick giant joins FTSE 100

Consumer health company ends first day on London Stock Exchange with £28.5bn market valuation

Five years ago, astronomers were electrified to confirm the discovery of Comet C/2017 K2, more commonly known as Comet K2. At the time, it was believed to be one of the largest comets zooming across the universe, with a nucleus believed to be around 11 miles in diameter and a…

After decades of work, the World Health Organization endorsed the first-ever malaria vaccine last year - a historic milestone that promised to drive back a disease that kills a child every minute.

Here's a roundup of top developments in the biotech space over the last 24 hours:

Nigerian photographer Yagazie Emezi travels across her home country to document the ongoing epidemic of child pneumonia

The new recommendation reduces the period within which patent applications can be challenged to six months

Ideaya Biosciences Inc (NASDAQ:IDYA) has selected a potential first-in-class Pol Theta Helicase development candidate, a small molecule inhibitor of the helicase domain of DNA Polymerase Theta.  Ideaya is collaborating with GSK plc (NYSE:GSK) on IND-enabling studies to support the evaluation of the Pol Theta Helicase candidate in combination with niraparib, GSK's PARP inhibitor, in tumors with…

GSK announced positive results in a late-stage study on a new Covid-19 vaccine targeted to combat the omicron variant.

GSK plc (NYSE:GSK) announced promising interim results from the B-Clear phase 2b trial of bepirovirsen in people with chronic hepatitis B (CHB). The data showed that bepirovirsen reduced hepatitis B surface antigen (HBsAg) levels and hepatitis B virus (HBV) DNA after 24 weeks of treatment. In the group of 227 patients on standard…

Sanofi stock bounded higher Friday after its GSK-partnered Covid shot tamped down on omicron infections in a Phase 3 study.